Mary Chapman, features writer —

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and 23andMe announced the launch of a data and analytics resource for researchers, based on patient experiences, that aims to improve clinical trial design and, subsequently, therapies for Parkinson’s. Called the Fox Insight Data Exploration Network (Fox DEN),…

In support of local health, wellness and educational programs, the Parkinson’s Foundation is granting $1.5 million to Parkinson’s community programs in 38 states. Grants range from $5,000 to $25,000, and focus on programs that either help underserved Parkinson’s disease communities, target newly diagnosed patients, or advocate for clinical trial…

The non-profit Parkinson’s Foundation will host its annual fundraiser, the New York Gala, on May 7, with a goal of surpassing the $750,000 raised last year. The event’s master of ceremonies will be Willie Geist, host of NBC News’ “Sunday Today with Willie Geist,” and co-host of…

Acadia Pharmaceuticals is marking Parkinson’s Awareness Month by supporting a host of events and activities in April throughout the U.S. Although some events have occurred, several are annual events needing participation. “We encourage patients and their families to attend an event, which includes important resources to help them…

In partnership with the Edmond J. Safra Foundation, The Michael J. Fox Foundation (MJFF) for Parkinson’s Research has announced five academic centers chosen for the Edmond J. Safra Fellowship in Movement Disorders to train the Class of 2022. Each year, the five-year-old fellowship provides funding to five research centers…

Christina Korines was 22 — a recent college graduate and a newly minted Spanish teacher — when she noticed a tremor in her right foot. That tremor soon progressed into a pronounced limp, and an arm that didn’t swing when she walked. Something was terribly wrong, she just didn’t know…

With the goal of advancing Parkinson’s disease (PD) diagnosis and therapy by securely and safely sharing patient-produced data, the healthcare artificial intelligence (AI) company ConnectedLife is partnering with the technology platform Ocean Protocol. The collaboration marries the Internet of Things (IoT) — connected devices able to communicate…

As it sometimes happens in rare-disease research, a prospective therapy for one disorder has potential to help another. So it is that, at Temple University, molecular pharmacologist Marlene Jacobson, PhD, has been awarded a joint grant to explore how a discovery could affect Parkinson’s disease (PD) patients. Specifically,…

To further support its quest to advance a new therapy for Parkinson’s disease and related disorders, Inhibikase Therapeutics has added three leading researchers to its Scientific Advisory Board (SAB). The pharmaceutical company is developing protein kinase inhibitors for the treatment of neurological infections and neurodegenerative diseases. Its pipeline…

The National Institutes of Health (NIH) has granted a Michigan State University scientist $5 million to study a possible link between pesticides, a diminished sense of smell, and early symptoms of diseases such as Parkinson’s among older farmers. The investigator is Honglei Chen, MD, PhD, a professor of…